Diretrizes internacionais

Reino Unido

Cladribine for treating relapsing–remitting multiple sclerosis

Publicada por:National Institute for Health and Care Excellence

Última publicação:2024

Multiple sclerosis in adults: management

Publicada por:National Institute for Health and Care Excellence

Última publicação:2022

Cannabis-based medicinal products

Publicada por:National Institute for Health and Care Excellence

Última publicação:2021

Neuropathic pain in adults: pharmacological management in non-specialist settings

Publicada por:National Institute for Health and Care Excellence

Última publicação:2020

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

Publicada por:Association of British Neurologists

Última publicação:2015

Europa

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

Publicada por:European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)/European Academy of Neurology (EAN)

Última publicação:2018

EFNS guideline on the use of anti-interferon beta antibody measurements in multiple sclerosis

Publicada por:European Academy of Neurology

Última publicação:2011

Use of imaging in multiple sclerosis

Publicada por:European Academy of Neurology (European Federation of Neurological Societies)

Última publicação:2011

América do Norte

Clinical guidance in neuropalliative care: an AAN position statement

Publicada por:American Academy of Neurology

Última publicação:2022

Consensus recommendations on the use of MRI in patients with multiple sclerosis

Publicada por:Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS); Consortium of Multiple Sclerosis Centres (CMSC); North American Imaging in Multiple Sclerosis Cooperative (NAIMS)

Última publicação:2021

Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis

Publicada por:American Academy of Neurology

Última publicação:2019 (reaffirmed 2022)

The use of disease-modifying therapies in multiple sclerosis: principles and current evidence

Publicada por:MS Coalition

Última publicação:2019

Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis

Publicada por:American Academy of Neurology

Última publicação:2018 (reaffirmed 2024)

Clinical practice guideline: multiple sclerosis and management of urinary tract infection

Publicada por:Toward Optimized Practice, Alberta

Última publicação:2017

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis

Publicada por:American Academy of Neurology

Última publicação:2014 (re-affirmed 2023)

Evidence-based guideline: assessment and management of psychiatric disorders in individuals with multiple sclerosis

Publicada por:American Academy of Neurology

Última publicação:2014 (re-affirmed 2019)

Restante do mundo

International consensus on quality standards for brain health-focused care in multiple sclerosis

Publicada por:Multiple Sclerosis Journal

Última publicação:2018

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Publicada por:International Panel on Diagnosis of MS

Última publicação:2018

International validation protocol: recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS)

Publicada por:BICAMS Committee

Última publicação:2012

O uso deste conteúdo está sujeito ao nosso aviso legal